Intervention of cGAS‒STING signaling in sterile inflammatory diseases. (27th January 2022)

• Record Type: Journal Article
• Authors: Hong, Ze; Mei, Jiahao; Guo, Hanli; Zhu, Juanjuan; Wang, Chen
• Editors: Liu, Feng
• Is Part Of: Journal of molecular cell biology. Volume 14:Number 2(2022)
• Publication Date: 2022-01-27
• Subjects: cGAS -- STING -- DNA -- sterile inflammatory disease -- antagonist; Molecular biology -- Periodicals; 571.605
• DOI: 10.1093/jmcb/mjac005
• Languages: English
• ISSNs: 1674-2788

Abstract

Abstract: Sterile inflammation characterized by unresolved chronic inflammation is well established to promote the progression of multiple autoimmune diseases, metabolic disorders, neurodegenerative diseases, and cardiovascular diseases, collectively termed 'sterile inflammatory diseases'. By recognizing host-derived DNA, cyclic guanosine monophosphate–adenosine monophosphate synthase (cGAS) activates endoplasmic reticulum-associated stimulator of interferon genes (STING), which leads to the induction of type I interferons and inflammatory cytokines or immunogenic cell death that promotes sterile inflammation. Additionally, the DNA/cGAS-independent mode of STING activation has also been characterized in the progression of several sterile inflammatory diseases. This review focuses on the molecular mechanism of cGAS-dependent and cGAS-independent STING signaling under various disease conditions, particularly highlighting the diverse initiators upon this signaling pathway. We also summarize recent advances in the discovery of antagonists targeting cGAS and STING and the evaluation of their efficiencies in preclinical models. Finally, we discuss potential differences in the clinical applications of the specific antagonists, which may shed light on the precision therapeutic interventions.